Clinical trial
Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis, a Randomized, Double Blind, Placebo Controlled Study
NCT01930604 is registered in ClinicalTrials.gov with Carl Swartling as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis, a Randomized, Double Blind, Placebo Controlled Study
- Lead sponsor
- Carl Swartling
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- October 31, 2019
- Enrollment
- 588 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.